Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02693730 · ClinicalTrials.gov registry record
Phenotyping IBS: Perceptions and Modulations of Visceral Sensations
A clinical trial, sponsored by University of California, Los Angeles.
- Completed
- Registry status
- 198
- Enrollment target
NCT02693730 is a clinical trial that has completed, run by University of California, Los Angeles. The registered enrollment target is 198 participants.
The verdict
NCT02693730 has completed, sponsored by University of California, Los Angeles.
- COMPLETED
- Registry status
- 198 participants
- Enrollment target
Study Summary
The purpose of this research study is to improve the understanding of irritable bowel syndrome (IBS) and its underlying cause. The investigators will use magnetic resonance imaging (MRI) to observe differences in the brain between people diagnosed with IBS compared to healthy controls and people with ulcerative colitis, a disease group that has already been characterized. By doing this correlative and comparative study, the investigators hope to gain knowledge on IBS in order to keep the field moving in the right direction and becoming one step closer to discovering effective treatments.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 198 participants |
| Start Date | 2016-01 |
| Est. Completion | 2021-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02693730
The ClinicalTrials.gov registry entry for NCT02693730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 198 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, Los Angeles, which has 897 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02693730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02693730 about?
NCT02693730 is a clinical study titled "Phenotyping IBS: Perceptions and Modulations of Visceral Sensations". The purpose of this research study is to improve the understanding of irritable bowel syndrome (IBS) and its underlying cause. The investigators will use magnetic resonance imaging (MRI) to observe differences in the brain between people diagnosed with IBS compared to healthy controls and people wit...
What is the current status of trial NCT02693730?
This trial is currently completed. The enrollment target is 198 participants. The study started on 2016-01. Estimated completion is 2021-06.
Who is sponsoring clinical trial NCT02693730?
This trial is sponsored by University of California, Los Angeles, which has 897 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.